SG Americas Securities’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-5,899
| Closed | -$106K | – | 3817 |
|
|
2020
Q2 | $106K | Sell |
5,899
-20,623
| -78% | -$287K | ﹤0.01% | 3340 |
|
|
2020
Q1 | $189K | Buy |
26,522
+16,255
| +158% | +$203K | ﹤0.01% | 2546 |
|
|
2019
Q4 | $245K | Buy |
+10,267
| New | +$283K | ﹤0.01% | 2336 |
|
|
2019
Q2 | – | Sell |
-6,645
| Closed | -$231K | – | 3603 |
|
|
2019
Q1 | $231K | Sell |
6,645
-14,412
| -68% | -$416K | ﹤0.01% | 2470 |
|
|
2018
Q4 | $411K | Buy |
+21,057
| New | +$433K | ﹤0.01% | 1993 |
|
|
2018
Q3 | – | Sell |
-3,739
| Closed | -$141K | – | 3597 |
|
|
2018
Q2 | $141K | Sell |
3,739
-187
| -5% | -$7.15K | ﹤0.01% | 2852 |
|
|
2018
Q1 | $128K | Buy |
+3,926
| New | +$172K | ﹤0.01% | 2751 |
|
|
2017
Q4 | – | Sell |
-6,079
| Closed | -$328K | – | 3824 |
|
|
2017
Q3 | $328K | Sell |
6,079
-2,555
| -30% | -$150K | ﹤0.01% | 2163 |
|
|
2017
Q2 | $485K | Buy |
+8,634
| New | +$346K | ﹤0.01% | 1888 |
|
|
2017
Q1 | – | Sell |
-4,553
| Closed | -$102K | – | 3673 |
|
|
2016
Q4 | $102K | Sell |
4,553
-140,802
| -97% | -$2.75M | ﹤0.01% | 2862 |
|
|
2016
Q3 | $3.3M | Buy |
+145,355
| New | +$3.41M | 0.03% | 482 |
|
|
2016
Q2 | – | Sell |
-60,487
| Closed | -$1.23M | – | 3148 |
|
|
2016
Q1 | $1.23M | Buy |
60,487
+58,382
| +2,773% | +$1.85M | 0.01% | 1177 |
|
|
2015
Q4 | $108K | Sell |
2,105
-7,917
| -79% | -$384K | ﹤0.01% | 2376 |
|
|
2015
Q3 | $427K | Buy |
+10,022
| New | +$484K | ﹤0.01% | 1115 |
|
|
2015
Q2 | – | Sell |
-6,742
| Closed | -$256K | – | 2931 |
|
|
2015
Q1 | $256K | Sell |
6,742
-1,088
| -14% | -$37.4K | ﹤0.01% | 1764 |
|
|
2014
Q4 | $222K | Buy |
+7,830
| New | +$218K | ﹤0.01% | 2342 |
|
|
2014
Q1 | – | Sell |
-977,990
| Closed | -$25.2M | – | 2883 |
|
|
2013
Q4 | $25.2M | Buy |
+977,990
| New | +$23.8M | 0.1% | 190 |
|
SG Americas Securities's PTLA Position: Q3 2020 in Review
SG Americas Securities sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 5,899 shares — an estimated $106K sold.
SG Americas Securities first reported a position in PTLA in Q4 2013 and held it in 17 quarters. The position peaked at $25.2M in Q4 2013. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- SG Americas Securities reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- SG Americas Securities sold 5,899 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $106K.
- SG Americas Securities first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 17 quarters.
- SG Americas Securities's Portola Pharmaceuticals, Inc. position peaked at $25.2M in Q4 2013.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.